Aine Miller

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Brett A Grimaud, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aine Miller:

Company Role Class Num Shares Value Price $ Report Date Ownership
Theravance Biopharma, Inc. SVP, DEV & HEAD OF IRE OFFICE Ordinary Shares 184,161 $3,620,605 $19.66 20 Feb 2026 Direct

Insider Reports Filed by Aine Miller

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TBPH Theravance Biopharma, Inc. 20 Feb 2026 1 -$331,291 4 SVP, DEV & HEAD OF IRE OFFICE 24 Feb 2026, 19:38
TBPH Theravance Biopharma, Inc. 20 Nov 2025 1 -$125,103 4 SVP, DEV & HEAD OF IRE OFFICE 24 Nov 2025, 18:15
TBPH Theravance Biopharma, Inc. 20 Aug 2025 1 -$93,583 4 SVP, DEV & HEAD OF IRE OFFICE 22 Aug 2025, 18:05
TBPH Theravance Biopharma, Inc. 19 May 2025 2 -$91,674 4 SVP, DEV & HEAD OF IRE OFFICE 21 May 2025, 19:22
TBPH Theravance Biopharma, Inc. 28 Feb 2025 1 $0 4 SVP, DEV & HEAD OF IRE OFFICE 04 Mar 2025, 18:09
TBPH Theravance Biopharma, Inc. 20 Feb 2025 1 -$109,110 4 SVP, DEV & HEAD OF IRE OFFICE 24 Feb 2025, 19:28
TBPH Theravance Biopharma, Inc. 20 Nov 2024 1 -$100,458 4 SVP, DEV & HEAD OF IRE OFFICE 22 Nov 2024, 18:08
TBPH Theravance Biopharma, Inc. 20 Aug 2024 1 -$42,752 4 SVP, DEV & HEAD OF IRE OFFICE 22 Aug 2024, 20:06
TBPH Theravance Biopharma, Inc. 20 May 2024 1 -$47,329 4 SVP, DEV & HEAD OF IRE OFFICE 22 May 2024, 18:06
TBPH Theravance Biopharma, Inc. 02 Apr 2024 1 $0 4 SVP, DEV & HEAD OF IRE OFFICE 04 Apr 2024, 18:13
TBPH Theravance Biopharma, Inc. 20 Feb 2024 1 -$105,095 4 SVP, DEV & HEAD OF IRE OFFICE 22 Feb 2024, 20:10
TBPH Theravance Biopharma, Inc. 06 Feb 2024 0 $0 3 SVP, Dev & Head of IRE Office 16 Feb 2024, 20:12